425: Matinas BioPharma to Combine with Clean Energy Firm GH Power

Matinas BioPharma Holdings, Inc. announced a business combination with GH Power Inc., a clean energy and critical minerals company, aiming to list on the NYSE American.

Summary

• Matinas BioPharma Holdings, Inc. has entered into a definitive agreement for a business combination with GH Power Inc., a Canadian clean energy and critical minerals company.
• GH Power develops modular hydrogen reactors that use scrap metals and water to produce clean hydrogen and thermal energy, with no fossil fuels required.
• The combined entity, expected to be named GH Power International Inc., will be an Ontario corporation.
• GH Power shareholders are anticipated to hold approximately 91% of the combined entity, with Matinas shareholders holding the remaining 9%, subject to adjustments.
• The combined company is expected to list on the NYSE American stock exchange, pending approval and satisfaction of listing standards.
• The transaction requires GH Power to complete a minimum $15 million financing before closing, targeted for Q4 2026.
• The parties anticipate that GH Power International Inc. will focus on commercializing GH Power's modular reactor technology.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as moderately positive, as it represents a strategic move into the growing clean energy sector with innovative technology, but significant financing and regulatory hurdles remain.

Positives

• GH Power's technology offers a novel approach to clean energy production by utilizing scrap metals and water to create hydrogen and thermal energy.
• The modular and scalable nature of GH Power's reactors allows for on-site deployment, potentially reducing logistical complexities.
• The business combination provides Matinas BioPharma with an opportunity to enter the clean energy and critical minerals sector.
• The combined company is targeted for listing on the NYSE American, offering potential access to public capital markets.
• Both companies' boards have unanimously approved the combination, indicating strong internal support.

Negatives

• Matinas BioPharma shareholders will hold a minority stake (approximately 9%) in the combined entity.
• The business combination is contingent on GH Power securing a minimum $15 million financing, which is a significant hurdle.
• The transaction is subject to numerous closing conditions, including regulatory approvals, shareholder approvals, and listing requirements, creating uncertainty.
• The Form F-4 registration statement has not yet been filed, indicating the process is still in its early stages.

Risks

• The risk that the proposed business combination may not be completed in a timely manner or at all.
• Failure to satisfy closing conditions, including Matinas stockholder approval, GH Power securityholder approval, Ontario court approvals, effectiveness of the Form F-4 registration statement, completion of GH Power financing ($15.0 million minimum), GHP International qualifying as a foreign private issuer, and listing on the NYSE American.
• Failure to realize the anticipated benefits of the proposed business combination.
• Costs associated with the proposed business combination and becoming a public company.
• Changes in business, market, financial, political, and regulatory conditions.
• Risks relating to GH Power's anticipated operations and business, including the commercialization of its technology.
• The outcome of any legal proceedings that may be instituted against the parties following the announcement.
• Risks detailed in Matinas's SEC filings, including its Form 10-K for the fiscal year ended December 31, 2025.

Future Outlook

The combined company, GH Power International Inc., is expected to focus on the commercialization of GH Power's modular reactor technology. The transaction is targeted for closing in the fourth quarter of 2026, subject to satisfaction of closing conditions, and aims for a listing on the NYSE American.

Management Comments

• "I am excited to announce that we have signed a definitive agreement to go public through a business combination with Matinas BioPharma."
• "GH Power is a clean energy and critical minerals company based in Ontario, Canada. We build modular hydrogen reactors that introduce a new class of energy technology."
• "Our reactors use scrap metals and water to create clean hydrogen and clean thermal energy heat. No fossil fuels are required."
• "It is a closed-loop system that transforms waste into value at industrial scale, and it produces three core outputs. Clean hydrogen fuel for industry, transport, and energy storage. Clean thermal energy, where steam from the reaction is captured and reused in the system. And high-purity aluminum oxide, a critical mineral for batteries, glass, and advanced materials."
• "Compact and scalable, the reactors can be deployed directly on site at factories, data centres, hospitals, and municipalities."
• "We believe we are pioneering work in metal fuels, and our company has been recognized globally."
• "We believe this proposed transaction marks an important milestone for GH Power as we continue working to advance our clean energy and critical minerals platform."

Industry Context

StockSavvy.ai notes that this business combination aligns with the growing global trend towards clean energy solutions and the increasing demand for critical minerals essential for advanced technologies like batteries and renewable energy infrastructure. GH Power's approach of converting waste materials into valuable energy and resources is particularly relevant in the current economic and environmental climate.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Matinas, GH Power, GHP International, or others following announcement of the proposed business combination is a risk factor.

Stakeholder Impact

• Shareholders: Matinas shareholders will hold a minority stake (approx. 9%) in the combined entity, subject to adjustments. GH Power shareholders are expected to hold the majority (approx. 91%).
• Employees: Potential for new opportunities within the combined clean energy and critical minerals company.
• Creditors: The financial health and stability of the combined entity will impact creditors.

Next Steps

• Filing of a registration statement on Form F-4 with the SEC.
• Matinas to mail a definitive proxy statement/prospectus to its stockholders after the Form F-4 is declared effective.
• Completion of GH Power's minimum $15 million financing.
• Satisfaction or waiver of other applicable closing conditions.
• Obtaining necessary shareholder and regulatory approvals.
• Listing of GHP International's securities on the NYSE American.

Key Dates

Recommendation

The announcement of a business combination with a clean energy company presents a growth opportunity, but the significant financing requirement and numerous closing conditions introduce substantial risk. A 'hold' recommendation is appropriate pending successful completion of the financing and closing conditions, and further clarity on the combined entity's operational and financial projections.

Keywords

GH Power, Matinas BioPharma, Business Combination, Clean Energy, Hydrogen Reactor, Critical Minerals, Public Listing, NYSE American